Subunit and Frequency-Dependent Inhibition of Acid Sensing Ion Channels by Local Anesthetic Tetracaine by Tiandong Leng et al.
MOLECULAR PAIN
Leng et al. Molecular Pain 2013, 9:27
http://www.molecularpain.com/content/9/1/27RESEARCH Open AccessSubunit and frequency-dependent inhibition of
Acid Sensing Ion Channels by local anesthetic
tetracaine
Tiandong Leng1, Jun Lin2, James E Cottrell2 and Zhi-Gang Xiong1*Abstract
Background: Extracellular acidosis is a prominent feature of multiple pathological conditions, correlating with pain
sensation. Acid-sensing ion channels (ASICs), a family of proton-gated cation channels, are distributed throughout
the central and peripheral nervous systems. Activation of ASICs, particularly ASIC3 and ASIC1a channels, by acidic
pH and the resultant depolarization of nociceptive primary sensory neurons, participates in nociception. Agents that
inhibit the activation of ASICs are thus expected to be analgesic. Here, we studied the effect of local anesthetic
tetracaine on ASIC currents.
Results: Tetracaine inhibited the peak ASIC3 current in a concentration-dependent manner with an IC50 of
9.96 ± 1.88 mM. The degree of inhibition by tetracaine was dependent on the extracellular pH but independent of
the membrane potential. Furthermore, 3 mM tetracaine also inhibited 29.83% of the sustained ASIC3 current. In
addition to ASIC3, tetracaine inhibited the ASIC1a and ASIC1β currents. The inhibition of the ASIC1a current was
influenced by the frequency of channel activation. In contrast to ASIC3, ASIC1a, and ASIC1β currents, ASIC2a current
was not inhibited by tetracaine. In cultured mouse dorsal root ganglion neurons, 1–3 mM tetracaine inhibited both
the transient and sustained ASIC currents. At pH4.5, 3 mM tetracaine reduced the peak ASIC current to
60.06 ± 4.51%, and the sustained current to 48.24 ± 7.02% of the control values in dorsal root ganglion neurons. In
contrast to ASICs, voltage-gated sodium channels were inhibited by acid, with 55.15% inhibition at pH6.0 and
complete inhibition at pH5.0.
Conclusions: These findings disclose a potential new mechanism underlying the analgesic effects of local
anesthetics, particularly in acidic conditions where their primary target (i.e. voltage-gated Na+ channel) has been
suppressed by protons.
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Acid-Sensing Ion Channels (ASICs), members of the
degenerin/epithelial sodium channel (Deg/ENaC) super-
family, are abundantly distributed in the central and per-
ipheral neurons [1,2]. All ASICs contain two hydrophobic
transmembrane domains surrounding a large extracellular
loop and relatively short intracellular NH2- and COOH-
terminal domains [3]. In rodents, there exist at least six
ASIC subunits including ASIC1a, ASIC1b(β), ASIC2a,
ASIC2b, ASIC3 and ASIC4 [4]. ASIC1a and ASIC2a are* Correspondence: ZXiong@msm.edu
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reproduction in any medium, provided the orabundant in the central and peripheral nervous system
while ASIC3 and ASIC1b are restricted to the peripheral
nervous system [5-7]. ASICs are H+-gated channels
sensitive to acidic pH to a varying extent depending on
the subunit composition of the channels. For example,
ASIC1a and ASIC3 are very sensitive to protons with
an activation threshold close to pH7.0. ASIC1a has a
pH0.5 of ~6.2 and mediates fast decaying, transient cur-
rents [8]. ASIC3 has two current components includ-
ing a peak component with a pH0.5 of ~6.2 and a
sustained current component with a pH0.5 of ~4.3
[5,9]. Similar to ASIC1a, ASIC1b has a pH0.5 of ~6.0
and mediates a transient current [6,10]. ASIC2a has low
sensitivity to acidic pH with a pH0.5 of ~4.4 [11]. ASIC2bd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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own [12-14]. Activation of ASICs by protons induces
sodium (and calcium for homomeric ASIC1a channels)
influx, resulting in membrane depolarization and neur-
onal excitation. Several studies have shown that ASICs
play important roles in physiological processes such as
nociception [15-19], synaptic plasticity and learning/
memory [20], and in pathological conditions such as
brain ischemia [21-24], seizure [25], multiple sclerosis
[26], and tumor cell migration [27,28].
In painful conditions such as ischemia, skin and muscle
incision, arthritis and inflammation, protons are produced
or released by the injured tissues, resulting in tissue acidosis
[4,29,30]. For example, the fall of local pH to 5.4 in inflam-
mation and to 4.7 in fracture-related hematomas have been
documented [31]. It has been demonstrated that accumula-
tions of protons depolarize the terminals of nociceptive
primary sensory neurons to cause pain sensation, and that
the depolarization is caused by a direct activation of proton
gated ionic channels [32,33]. Although both ASICs and
Transient Receptor Potential Vanilloid receptor type 1
(TRPV1) could be involved, recent studies have suggested
that ASICs, rather than TRPV1, mediate pain sensation
induced by acid injection [17,34]. Although ASIC1a and
ASIC3 have been implicated in acute pain sensation,
ASIC3, the subunit that conducts both transient and
sustained currents [5], may have a unique role in pain
sensation in chronic conditions [17,29,35].
Local anesthetics have multiple effects including
antinociception and analgesia, antiarrhythmia, and
neuroprotection [36-38]. Blockage of voltage-gated sodium
channels is a well-known and medically important mechan-
ism of local anesthetics [39]. However, other mechanisms
are likely to be involved particularly in the conditions of
severe acidosis where the activities of voltage-gated sodium
channels are already diminished by acidic pH [40-42]. Since
ASICs in peripheral sensory neurons are implicated in
nociception, and our previous studies showed an inhibitory
effect of lidocaine on ASICs in mouse cortical neurons
[43], we hypothesize that local anesthetics such as tetra-
caine might suppress the ASIC currents mediated by ASIC
subunits that are highly and/or preferentially expressed in
peripheral primary sensory (e.g. DRG) neurons. Tetracaine
was approved and is still used as local anesthetic, which
has the potential in neuraxial anesthesia or infiltrative
anesthesia. Compared to lidocaine as well as other local
anesthetics, tetracaine has a longer duration, particularly in
the presence of a constrictor, which may render tetracaine a
desirable local anesthetic alone or combined with other
local anesthetics, in plexus/major nerve block for acute or
chronic pain management. Here, we demonstrate that
tetracaine inhibits ASIC currents expressed in Chinese
hamster ovary (CHO) cells and in native dorsal root
ganglion (DRG) neurons in a concentration range thatcan be reached for nerve blockade [44]. This finding
discloses a potential new mechanism underlying the
analgesic effects of tetracaine.
Results
Tetracaine inhibits ASIC3 current in a reversible and
concentration-dependent manner
In cultured CHO cells transfected with ASIC3 subunit, a
rapid reduction of pHo from 7.4 to 4.5 for 1 second evoked
a large transient inward current (Figure 1A). Following
the recording of stable ASIC3 currents, the effect of
tetracaine was tested by adding different concentra-
tions of tetracaine to the acidic solution. Addition of
3 mM tetracaine rapidly inhibited the peak current by
35.18% (n = 4, p < 0.01), and the inhibitory effect was
reversible after a short period of washout (Figure 1A-B).
At a lower concentration of 1 mM, a concentration
expected to be reached in clinical dosage range [45,46],
the amplitude of the ASIC3 current was reduced by
17.17% (p < 0.05, n = 4). More detailed dose–response
analysis yielded a threshold concentration of 0.3 mM
(6.82% inhibition) and a half-maximal inhibitory con-
centration of 9.96 ± 1.88 mM (n = 5, Figure 1C-D). For
unknown reason, higher concentration of tetracaine
(100 mM) caused an immediate loss of the tight seal in
all cells recorded (n > 5, data not shown).
Tetracaine inhibits ASIC3 current in a pH-dependent and
voltage-independent manner
Most local anesthetics are tertiary amines with pKa in
the range of 7 to 10. The fractions of uncharged free
amines and cationic protonated forms change with pH
[47]. Under acidic conditions, more protonated forms of
local anesthetics are available, which might limit their
inhibitory potency, as shown for voltage-gated sodium
channels. To determine whether the effect of tetracaine
on the ASIC3 current is also pH-dependent, we com-
pared the inhibitory effect of tetracaine on ASIC cur-
rents activated at pH4.5, pH6.0 and pH7.0. We found
no significant difference in the effect of tetracaine on
ASIC currents between pH6.0 and pH4.5 (30.16% inhib-
ition at pH6.0 and 29.43% inhibition at pH4.5, n = 4)
(Figure 2A-B, D). However, a 69.30% inhibition was ob-
served at pH7.0, which is significantly greater than those
at pH6.0 and pH4.5 (Figure 2C-D). These results suggest a
pH-dependent inhibition of the ASIC current by tetracaine.
To determine whether the inhibition of ASIC3 currents
by tetracaine is voltage-dependent, currents evoked by
lowering pHo from 7.4 to 4.5 were recorded over a range
of holding potentials from −60 to +60 mV with an
increment of 30 mV (Figure 2E). As shown in Figure 2F,
the current–voltage relationships were linear in the ab-
sence and presence of 3 mM tetracaine (n = 4), demon-
strating a lack of voltage dependence.
Figure 1 Reversible and concentration-dependent inhibition of ASIC3 currents by tetracaine. A, B. Representative current traces and
summary data showing reversible inhibition of the ASIC3 current expressed in Chinese Hamster Ovary cells (CHO) cells. ASIC3 current was
induced by decreasing the extracellular pH from 7.4 to 4.5. Tetracaine was added to the pH 4.5 solution at a final concentration of 3 mM
(Paired t test, n = 4; **p < 0.01). C, D. Representative current traces and summary data showing a concentration-dependent inhibition of the peak
amplitude of ASIC3 currents by tetracaine. The IC50 value was 9.96 ± 1.88 mM (n = 5). Data were expressed as mean ± SD.
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ASIC3 current is characterized by a fast desensitizing early
component followed by a sustained non-desensitizing late
component [4]. The sustained component, which persists
in the continuous presence of tissue acidosis, likely con-
tributes to prolonged depolarization of peripheral sensory
neurons and sensation of nonadapting pain [48,49]. To
investigate the potential inhibitory effect of tetracaine on
the non-desensitizing component of the ASIC3 current,
we perfused the cells with a pH 4.5 solution for 4 seconds
to evoke the sustained ASIC3 current (Figure 3A). As
shown in Figure 3A-B, 3 mM tetracaine significantly and
reversibly decreased the amplitude of the sustained current
by ~30% (n = 4, Figure 3A-B).
Tetracaine inhibits the ASIC1a current in a
frequency-dependent manner
ASIC1a is one of the most sensitive pH sensors in the
central and peripheral nervous system. Similar to ASIC3
channels, activation of ASIC1a channels has been impli-
cated in pain sensation [8,16,18,19]. Therefore, we also de-
termined whether tetracaine has an inhibitory effect on the
ASIC1a current. When pHo was decreased from 7.4 to 6.0,
a transient and prominent inward current was induced in
CHO cells transfected with complimentary DNA encoding
ASIC1a subunit (Figure 4A-B). In most cells, the amplitude
of ASIC1a currents decreased gradually within the first
10–15 min after formation of whole-cell configuration
but stabilized within ~20 min. Unless otherwise stated,
we only tested the effect of tetracaine 20 min after theformation of whole-cell recording and following the
recording of at least three stable currents. With 3 mM
tetracaine added in the acidic solution, the ASIC1a
current decreased progressively with repeated activation of
the channels (Figure 4B). 10 min after the start of tetracaine
exposure, approximately 80% of the ASIC1a current was
inhibited (Figure 4C). The current did not recover after
~10 min washout (Figure 4C). In the absence of tetracaine,
as a control, the ASIC1a current was relatively stable
within the same time period (Figure 4A, C).
Since tetracaine was only present in the low pH solution
and applied to cells for a few seconds every 2 min,
the gradual and time-dependent inhibition of the
ASIC1a current by tetracaine suggested a possibility
of frequency-dependency.
To provide more evidence of frequency-dependent
inhibition, we reduced frequency of channel activation from
5 times (Figure 4A-B) to 2 times (Figure 4D-E) during the
same time period from 4 min to 12 min. We found that the
inhibitory effect of tetracaine was significantly reduced
(Figure 4E-F). In the same paradigm, there was no reduc-
tion of the ASIC1a current in the absence of tetracaine
(Figure 4D). Thus, the inhibition of the ASIC1a current by
tetracaine is frequency-dependent. The higher frequency
the channel opens, the more inhibition takes place.
Effect of tetracaine on ASIC1β and ASIC2a currents
To further determine whether the effect of tetracaine is
subunit-dependent, we also investigated the effect of
tetracaine on ASIC1β and ASIC2a currents. As shown
Figure 2 pH-dependent and voltage-independent inhibition of ASIC3 currents by tetracaine. A, B, C. Representative current traces
showing inhibition of ASIC3 currents by 3 mM tetracaine at pH4.5, pH6.0, and pH7.0, respectively. D. Summary data showing inhibition of the
ASIC3 current by 3 mM tetracaine at different pH levels as indicated (t test, n = 4; *p < 0.05). E. Representative current traces showing ASIC3
current activated at different holding potentials ranging from −60 to +60 mV in the absence and presence of 3 mM tetracaine. F. Current–voltage
relationship (I-V curve) in the absence and presence of 3 mM tetracaine; n = 4.
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inward ASIC1β current. Addition of 3 mM tetracaine in
the acidic solution rapidly and reversibly decreased the
current amplitude by 52% (Figure 5B, n = 5). Unlike
ASIC1a, the inhibition of the ASIC1β current by tetracaine
does not show clear time or frequency-dependency. In
contrast to ASIC3, ASIC1a, and ASIC1β, ASIC2a current
was not affected by 1–3 mM tetracaine (Figure 5C). Inter-
estingly, higher concentrations (>10 mM) of tetracaine po-
tentiated the ASIC2a current (Figure 5C-D). We were,
however, unable to test the effect of 100 mM tetracaine
on any subunit of ASICs since it caused an immediate
loss of tight seal for an unknown reason.
Effect of tetracaine on acid-evoked current in primary
cultured DRG neurons
One potential limitation with the heterologous expression
system is that it may not represent the effect of tetracaine
on ASICs expressed in native neurons. To address this
issue, we also investigated the potential effect of tetracaine
on ASICs in mouse dorsal root ganglion (DRG) neurons.As reported previously [50,51], a biphasic ASIC3-like
current was induced when the extracellular pH was
lowered to 4.5 (Figure 6A), and addition of 1 mM tetracaine
reduced the amplitude of the peak and sustained current
activated at pH4.5 to 77.84% and 68.71% (Figure 6A-B).
However, only the transient current component was visible
when the extracellular pH was lowered to 6.0 as shown in
Figure 6C. The amplitude of the peak current activated at
pH6.0 was reduced to 74.23% by 1 mM tetracaine
(Figure 6C-D). As expected, 3 mM tetracaine produced a
greater reduction in the amplitude of ASIC currents.
At pH4.5, for example, the peak and sustained cur-
rents were reduced to 68.71% and 48.24%, respectively
(Figure 6C-D).
Acid inhibits voltage-gated Na+ currents in primary
cultured DRG neurons
To confirm the inhibition of voltage-gated Na+ current
by acidosis in DRG neurons in our recording condition,
we compared voltage-gated Na+ currents recorded in
normal solution (pH7.4) with that in acidic solution
Figure 4 Inhibition of the ASIC1a current by tetracaine. A, B and C. Repr
decrease of ASIC1a current after rundown in the absence (n = 3, black) and p
Bonferroni posttests, ***p < 0.001). D, E and F. Representative current traces an
ASIC1a current in the absence (n = 5, black) and presence (n = 4, red) of 3 mM
*p < 0.05; ***p < 0.001).
Figure 3 Inhibition of sustained ASIC3 current by tetracaine.
A, B. Representative current traces and summary data showing a
reversible inhibition of the steady state (SS) component of ASIC3 current
activated at pH 4.5 by 3 mM tetracaine (paired t test, n= 4; *p< 0.05).
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by step depolarization of the membrane potential
from −60 mV to −30, -20 and −10 mV. We found that the
amplitude of the inward Na+ currents was significantly
suppressed at pH6.0, with a 55.15% inhibition observed
at −30 mV (n = 6). Surprisingly, no inward Na+ current
was recorded at pH5.0 (Figure 7A-B).
Discussion
Acid sensing ion channels are proton-gated cation channels
[2,5], which play important roles in physiological processes
such as synaptic plasticity, learning and memory, and
pathological conditions such as brain ischemia, epilepsy,
and pain [17,20,22,52,53]. Activation of ASICs, such as
ASIC3 and ASIC1a, was implicated in pain sensation
[16-19]. In particular, the activation of ASIC3 has been
implicated in chronic pain sensation [35]. In contrast to
ASIC1a which only conducts a transient inward current,
ASIC3 can conduct a biphasic current: a rapidly desensitiz-
ing peak current and a sustained non-desensitizing current
that lasts as long as the extracellular pH remains acidic
[5,32,54]. The fast current component is likely related
to the onset of pain sensation while the sustained
current, which persistently depolarizes neuronal membrane,
may be implicated in longer lasting pain sensation. The
inhibitory effect of tetracaine on both components of
ASIC3 current may disclose a potential new mechanism
for its analgesic effects.
Under painful conditions, tissue pH may drop dramatic-
ally to different values depending on the location and theesentative current traces and summary data showing time-dependent
resence (n = 4, red) of 3 mM tetracaine (Two-way ANOVA followed by
d summary data showing the frequency-dependent inhibition of the
Tetracaine; (Two-way ANOVA followed by Bonferroni posttests,
Figure 5 Effect of tetracaine on ASIC1β and ASIC2a current. A, B. Representative current traces and summary data showing the inhibition of
ASIC1β current expressed in Chinese Hamster Ovary cells (CHO) cells by 3 mM tetracaine; (Paired t test, n = 5; ***p < 0.001). C, D. Representative
current traces and summary data showing the potentiation of the ASIC2a current in Chinese Hamster Ovary cells (CHO) cells by 10 and 30 mM
tetracaine (paired t test, n = 4; *p < 0.05, ***p < 0.001).
Figure 6 Inhibition of ASIC3-like current in dorsal root ganglion (DRG) neurons by tetracaine. A, B. Representative current traces and
summary data showing a reversible inhibition of the peak and steady state (SS) components of the ASIC3-like current activated at pH 4.5 by
1 mM and 3 mM tetracaine (paired t test, n = 4; *p < 0.05, **p < 0.01, ***p < 0.001). C, D. Representative current traces and summary data showing
a reversible inhibition of the amplitude of ASIC3-like current activated at pH 6.0 by 1 mM and 3 mM tetracaine. (paired t test, n = 5; ***p < 0.001).
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Figure 7 Inhibition of voltage-gated Na+ current by acid. A. Representative current traces showing the inhibition of voltage-gated Na+ currents
at pH 6.0 and 5.0 in DRG neurons. Neurons were held at -60 mV and stepped to potentials between −30 and −10 mV with 10 mV increments.
B. Summary data showing that the peak Na+ currents at −30 mV were inhibited by acid (paired t test, n = 6; *p < 0.05, ***p < 0.001).
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one of the most sensitive ASIC subunits, which can sense a
decrease of pH to 7.0 [57,58]. The significant inhibition of
tetracaine on the ASIC3 current, whether at a slight acid-
osis of pH 7.0 or severe acidosis of pH 4.5, suggests that it
may have analgesic effects in multiple painful disorders
with different degrees of acidosis. The finding that tetra-
caine is more effective in reducing the ASIC3 current at
pH 7.0 than pH 4.5 or 6.0 likely suggests that uncharged
forms of tetracaine are more effective in inhibiting the
ASIC current. It also indicates that, at pathological
conditions with minor pH drops, lower concentration
of tetracaine is needed to suppress ASIC3-mediated
nociceptive responses. There has been convincing in vivo
studies in animal and human that ASICs mediate the pain
perception induced by tissue acidosis [59,60]. Inflamma-
tion, a condition of local persistent acidosis, has also been
found to increase ASIC expression, which is believed to
account for hyperalgesia[61]. Local anesthetics exert their
primary action by blocking the nerve conductance. The
effect is mediated primarily by the blockage of sodium
channel from inside of the cell membrane [47]. In severe
acidic conditions (e.g. pH < 7.0), the penetration of localanesthetics into neuron is dramatically reduced by decrease
of the non-ionized form. Accordingly, its effect on
voltage-gated sodium channels is diminished in severe
acidic conditions [47]. In contrast to its action on sodium
channels, our studies showed that tetracaine still has
significant effect on ASIC current at pH level as low as
4.5. When injected to the local tissue with acidosis, the
effect of tetracaine would be compounded for its ac-
tion on sodium ion channel, ASICs, and potentially
others. Tetracaine inherently renders solution acidic,
which effect might counteract its inhibition on ASICs.
Considering this, we tested the effects of 3 mM tetracaine
without pH adjustment on ASIC3, ASIC1a and ASIC2a.
We found the slight pH drop of 0.01 caused by 3 mM
tetracaine didn’t prominently decrease the inhibitory
effect of tetracaine on ASICs (data not shown), comparing
with those with pH adjustment.
ASIC1a, the most abundant subunit in the central ner-
vous system, is also distributed in the peripheral nervous
system. Similar to ASIC3, the activation of ASIC1a is im-
plicated in pain sensation [4,16,18,19]. We showed that tet-
racaine inhibited both the ASIC3 and ASIC1a currents. In
addition, we found that tetracaine inhibited ASIC1a current
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channels were activated the greater the inhibition occurred.
This frequency-dependent inhibition of the ASIC1a current
should preferentially suppress high-frequency pathological
activation of ASIC1a currents, for example, during epileptic
seizure activities. Run-down is a characteristic of ASIC1a
current [62,63], which is prominent in the first 10–15 mi-
nutes of the recording. However, after this period, ASIC1a
current reaches a relatively steady state. To exclude the po-
tential interference by run-down phenomenon, the effect of
tetracaine on the ASIC1a current was tested 20 min after
the formation of whole-cell configuration when stable cur-
rents were recorded.
ASIC2a is another subunit of ASICs present in both
central and peripheral nervous systems. It can form
homomeric ASIC2a channels, and heteromeric channels
with ASIC1a [64]. In contrast to ASIC3 and ASIC1a,
ASIC2a currents were not inhibited by tetracaine at
1–3 mM. Interestingly, high concentrations of tetracaine
(10 or 30 mM) produced a potentiation of the ASIC2a
current. Because of immediate deterioration of the
tight seal after challenging the cells with tetracaine at
100 mM or higher, we were unable to perform the full
dose–response relationship study on ASIC2a as well as
ASIC3 currents. Unlike ASIC1a and ASIC3, the role of
ASIC2a in pain sensation was poorly understood. In
contrast to ASIC1a and ASIC3, ASIC2a is insensitive to
the drop of extracellular pH with a threshold pH of ~5.0
and pH0.5 of ~4.4 [11]. Such severe acidosis may rarely
happen even under pathological conditions. Thus, the
clinical implication of the potentiation of ASIC2a current
by higher concentrations of tetracaine remains to be
determined. Since ASIC2a currents can be potentiated by
high concentrations of zinc [65], whether tetracaine can
interact with zinc binding sites on this subunit could be
an interesting study in the future.
ASIC1β is a short form of ASIC1b. It shares a high
sequence similarity with ASIC1a. The difference be-
tween ASIC1a and ASIC1β lies in the first 175 aa
that includes short intracellular N-terminus, trans-
membrane domain I and a short extracellular segment.
Future studies using chimeric ASIC1a/1β that contains
different parts of the ASIC1β subunit may help in identify-
ing the specific domain and/or amino acids involved in the
effect of tetracaine.
Besides homomeric ASIC3, heteromeric ASIC1a/3 and
ASIC1b/3 could also participate in acid-activated current in
native sensory neurons, but their electrophysiological prop-
erties cannot be distinguish from the homomeric channels
[51]. The ASIC3-like current in DRG neurons that were
inhibited by tetracaine could be mediated by a combination
of homomeric and heteromeric ASIC3 channels.
Injecting a local anesthetic into tissues has been
used to block pain transmission for over a century.Although it is generally believed that blockade of
voltage-gated Na+ channels and nociceptive impulses
in the peripheral nerve fibers mediate the effect of
local anesthetics, other mechanisms are likely to be in-
volved in their interruption of nociceptive conduction in
the spinal cord. For example, bupivacaine inhibits sub-
stance P release with an IC50 of approximately 1 mM [66].
In addition, it blocks capsaicin-induced Transient Recep-
tor Potential Vanilloid receptor type 1 (TRPV1) current,
which plays an important role in the development of
hyperalgesia after injury [67]. Interestingly, TRPV1 current
could be activated and sensitized by lidocaine with an
EC50 of 12 mM [68]. More complex, quaternary lidocaine
derivative QX-314 exerts biphasic effects on TRPV1
channels, inhibiting capsaicin-evoked TRPV1 currents
at lower (micromolar) concentrations and activating
TRPV1 channels at higher (millimolar) concentrations
[69]. A recent study also demonstrated that lidocaine
is a potent blocker for Ih with an IC50 of 72 μM,
suggesting a potential new mechanism for systemic
analgesic actions of lidocaine [70].
It has been shown by several studies that the activity
of voltage-gated sodium channels, one of the primary
targets for local anesthetics, are dramatically inhibited
by acidic pH [40-42]. These findings are confirmed by
our study in DRG neurons (Figure 7). The outer ring
carboxylates of sodium channel can be protonated in an
acidic environment, which causes a significant reduction
of the single-channel conductance [71]. At the same
time, the protonation of local anesthetics under acidic
conditions could strongly decrease their potency for
block of Na+ current [47,72]. Thus, other molecular
mechanisms may be involved in the analgesic effects of
local anesthetics, particularly in conditions of severe
acidosis where the activities of Na+ channels are already
suppressed by protons. Our studies suggest that ASICs
might be an alternative target.
Our previous study found that lidocaine inhibits the
ASIC1a current in mouse cortical neurons at 1 mM con-
centration. Since ASIC1a is implicated in neurological
disorders such as brain ischemia while lidocaine can be
used systemically and showed neuroprotection in some
studies, inhibition of the ASIC1a current could be a po-
tential and alternative mechanism for its neuroprotective
effect. However, the concentration of lidocaine required
to inhibit the ASIC1a current is unlikely to be tolerable
for systemic use owing to the potential neuronal toxicity
reported even at a much lower concentration range [73].
On the contrary, local anesthetics are more commonly
used in the peripheral nervous system as analgesic agents.
Thus, the potential effect of local anesthetics on peripheral
ASICs may have more clinical relevance. Tetracaine could
inhibit ASIC3 and ASIC1a currents with a threshold con-
centration of 0.3 mM, and inhibit approximately 30% of
Leng et al. Molecular Pain 2013, 9:27 Page 9 of 11
http://www.molecularpain.com/content/9/1/27the ASIC current in DRG neurons at 1 mM. The formula-
tions of 1%-5% for local anesthetics in topical use corres-
pond to about ~40-200 mM. For example, a previous
study showed that tetracaine and its analog N-butyl tetra-
caine at 100 μM use-dependently inhibited ~80% of Na+
current measured at 30-s interval by the pulse protocol
[44]. However, 37 mM of N-butyl tetracaine (equivalent to
1.11% tetracaine-hyprochloric acid concentration) was
used to elicited sciatic nerve block. Another example
showed that tonicaine and lidocaine could inhibit 55% and
27.1% of the Na+ current at 100 μM. However, in vivo in-
jection of tonicaine at 1% lidocaine equivalent concen-
tration (42.67 mM) was used to elicit complete
functional block for withdrawal response to pinch [74].
This difference of effective concentrations between the
in vitro and in vivo model might be caused by the fac-
tors such as the permeability of the neural sheath, the
absorption or diffusion of these compounds in the sur-
rounding tissues. Additionally, other mechanisms might
be involved, for instance our study showed that tetra-
caine inhibits ASICs at mM concentrations which are
more closed to the concentrations used in the above
two studies. Although the final concentration in the
local tissue is difficult to measure, even a 100 time dilu-
tion could result in millimolar concentration.
Conclusions
ASICs are implicated in pain sensation, and local anesthetics
have analgesic effects. In the present study, we demonstrated
that tetracaine can frequency-dependently inhibit the
ASIC1a current and concentration-dependently inhibits the
ASIC3 current. Inhibition of ASIC1a and ASIC3 activity by
tetracaine discloses a potential novel mechanism for the an-
algesic effects of tetracaine, particularly in acidic conditions
where its conventional target (voltage-gated Na+ channels)
has already been suppressed by H+.
Methods
Culture of CHO cells and ASICs transfection
CHO cells were cultured in 35 mm dishes with F12K
medium (Invitrogen, Carlsbad, CA, USA) containing
10% fetal bovine serum (Invitrogen, Carlsbad, CA, USA),
50 units/ml penicillin, and 50 μg/ml streptomycin. At ~50%
confluence, cells were transfected with complimentary
DNA for rat ASIC1a fused with a green fluorescence
protein (GFP) at the c-terminal [75], or cotransfected
with complimentary DNAs for rat ASIC1β, ASIC2a or
ASIC3 with that for GFP, as described previously [76].
GFP-positive Cells were used for electrophysiological
recordings 24-72 h after transient transfection.
Primary culture of DRG neurons
Dorsal root ganglia were dissected from embryonic Swiss
mice at 16 days of gestation, enzymatically dissociated with0.25% trypsin for 10 min, and plated in poly-D-lysine
coated dishes. Cells were initially cultured in DMEM
containing 10% fetal bovine serum (FBS) and 10% horse
serum and maintained at 37°C in a humidified 5% CO2
atmosphere incubator. After 24 h, culture medium was
replaced with Neurobasal medium supplemented with B27
and glutamax. The cultures were fed twice a week and used
for electrophysiological recordings 6 ~ 8 days after plating.
Electrophysiology
ASICs currents were recorded with the whole-cell
patch-clamp and fast perfusion techniques, as previously
described [22]. GFP-positive CHO cells were selected for
the recordings of ASIC currents. As for DRG neurons,
only those cells that have typical long processes as
well as voltage-gated Na+ current were used for ASICs
recording. For fast-perfusion, a multibarrel perfusion
system (SF-77B, Warner Instruments, Hamden, CT) was
used. Patch pipettes were pulled from borosilicate glass.
Pipettes had a resistance of 2–4 MΩ when filled with the
intracellular solution. Whole-cell currents were recorded
using Axopatch 200B amplifiers (Axon Instruments, Foster
City, CA). All data were filtered at 2 kHz and digitized at
5 Hz using Digidata 1320 DAC units (Axon Instruments).
The on-line acquisition was done using pCLAMP software
(version 9.2, Axon Instruments). The recordings with an
access resistance of less than 10 MΩ and a leak current less
than 100 pA at −60 mV were included for data analysis
[75]. Extracellular acidic solution was applied for 1 s or 4 s
as indicated, with an interval of 1.5 or 2 min. The maximal
inward current value was measured as the peak current.
The sustained current for ASIC3 subunits was measured at
the end of 4 s perfusion of the acidic solution. Since
ASIC1a currents show significant rundown in the first
10–15 min after establishing the whole-cell configuration,
in general, the effect of tetracaine (Sigma-aldrich, Inc, St.
Louis, MO. USA) was tested ~20 min after the formation
of whole-cell configuration and following the recording of
at least three stable ASIC currents
Solutions and chemicals
Extracellular solution contained (mM): 140 NaCl, 5.4 KCl,
20 HEPES, 10 Glucose, 2 CaCl2, 1 MgCl2, pH 7.4 - 4.5, ad-
justed with NaOH and HCl, 320–330 mOsm. Intracellular
solution contained (mM): 140 CsF, 1 CaCl2, 10 HEPES,
11 EGTA, 2 TEA, 4 MgCl2, pH 7.3, adjusted with
CsOH, 290–300 mOsm [77]. Tetracaine hydrochloride
was dissolved in pH 6.0 or pH 4.5 extracellular solutions.
A slight drop of pH was noticed, which was corrected
with NaOH.
Statistical analysis
All data were expressed as mean ± SD. GraphPad Prism
4 and Sigma Plot were used for statistical analysis. ANOVA
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http://www.molecularpain.com/content/9/1/27followed by Bonferroni posttests or student’s t test were
used to examine the statistical significance. The criterion
for significance was set at p < 0.05. The dose–response
curve was fitted with 3 parameter logistic nonlinear regres-
sion model: y = a/(1 + (x/x0)^b), where a is the relative max-
imal current, x0 is C50 and b is the Hill coefficient.
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